Quick Answer
ENvue Medical, Inc. reported Cash And Cash Equivalents At Carrying Value of $7.74 million for the year ending 2021.
- ENvue Medical, Inc. showed an increase of +8.3% in Cash And Cash Equivalents At Carrying Value from 2020 to 2021.
- This data is from ENvue Medical, Inc.'s annual report (Form 10-K), filed with the SEC on April 15, 2022.
- XBRL data for this metric is available from 2013 to 2021 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2014: $106.0 thousand | Q3 2014: $38.0 thousand | Q1 2015: $2.80 million | Q2 2015: $2.26 million | Q3 2015: $1.99 million | Q1 2016: $1.28 million | Q2 2016: $799.0 thousand | Q3 2016: $532.0 thousand | Q1 2017: $51.0 thousand | Q2 2017: $215.0 thousand | Q3 2017: $82.0 thousand | Q1 2018: $3.49 million | Q2 2018: $2.52 million | Q3 2018: $1.73 million | Q1 2019: $184.0 thousand | Q2 2019: $2.37 million | Q3 2019: $2.26 million | Q1 2020: $93.0 thousand | Q3 2020: $3.18 million | Q1 2021: $7.95 million | Q2 2021: $5.67 million | Q3 2021: $8.60 million | Q4 2021: $7.74 million | Q1 2022: $5.99 million | Q3 2024: $1.31 million | Q4 2024: $752.0 thousand | Q2 2025: $4.03 million | Q3 2025: $6.95 million.
- Over the full 9 years of available data (2013 to 2021), ENvue Medical, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 8,130.9%.
- Historical annual values: Fiscal year 2021: $7.74 million | Fiscal year 2020: $7.14 million | Fiscal year 2019: $1.34 million | Fiscal year 2018: $896.0 thousand | Fiscal year 2017: $4.36 million | Fiscal year 2016: $106.0 thousand | Fiscal year 2015: $1.61 million | Fiscal year 2014: $90.0 thousand | Fiscal year 2013: $94.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: